• Health & Medicine

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.   Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

18 June 2021

• Health & Medicine

Combination immunotherapy for advanced bowel cancer approved for NHS in England

People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England. People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.

16 June 2021

• Science & Technology
• Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

9 June 2021

• Health & Medicine

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England. Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

8 June 2021

• Health & Medicine

Common anti-inflammatory drug could boost cancer immunotherapy

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery. Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

26 May 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• Health & Medicine
• Policy & Insight

Opinion: ‘Wales needs more than a three-page statement to get cancer services back on track’

The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable. The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable.

22 March 2021

• Health & Medicine

Could proton beam therapy improve throat cancer treatment?

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment. The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

15 March 2021

• Health & Medicine

2,000 fewer people in England began cancer treatment in January

The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020. The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.

11 March 2021

• Health & Medicine

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England. A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

9 February 2021

• Health & Medicine

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services. There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

2 February 2021

• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021